(Q46840795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Farid Nakhoul

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Afif Yaccob

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hiroshi Kawachi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tony Karram

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Huda Awaad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Nakhoul Nakhoul

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Aaron Hoffman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Zaid Abassi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

19 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

F628-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094029%20AND%20SRC:MED&resulttype=core&format=json

Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Broadening the spectrum of diseases related to podocin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Molecular structure-function relationship in the slit diaphragm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Aldosterone blockade: an emerging strategy for abrogating progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Aldosterone receptor blockade and the role of eplerenone: evolving perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Specific nongenomic actions of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Expression of nephrin in acquired human glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Hereditary proteinuria syndromes and mechanisms of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

CD2-associated protein directly interacts with the actin cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Nephrin in experimental glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Aldosterone and renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Early glomerular filtration defect and severe renal disease in podocin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Aldosterone target organ protection by eplerenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Beneficial impact of spironolactone in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Combination ACEI and ARB therapy: additional benefit in renoprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00524.2007